Protein Expression Kit Speeds Time-to-Market for Biotherapeutics

Invitrogen launched the GIBCO® OptiCHO™ Protein Express Kit, a new integrated solution for simple and efficient serum-free development of stable cell lines for biotherapeutic development. This
is the first kit of its kind to provide cells banked under cGMP conditions, allowing biotherapeutics manufacturers to speed regulatory submissions and time-to-market. The GIBCO OptiCHO Protein Express Kit incorporates all of the reagents, protocols and documentation required to go from gene to stable cell clones expressing the protein of interest, using a completely serum-free process. All of the products in the workflow are animal-origin free, supporting biomanufacturers to enhance the safety of human therapeutics. The kit is available for research use, however, laboratories interested in pursuing regulatory filings and require a documentation package, can obtain a commercial use license for a one-time fee, with no maintenance costs or royalties.

The OptiCHO Protein Expression Kit can be used as part of a complete workflow for stable cell line development that can be enhanced with the Countess™ Automated Cell Counter to simplify the cell counting steps of the protocol. Optimised components in the kit, such as TOPO® TA Cloning® Kits allow faster, more efficient creation of vectors, and FreeStyle™ MAX Transfection Reagent provide highly efficient, animal origin-free lipid transfection.